Webster Brian Daniel 4

What Happened Brian Daniel Webster, President and Chief Executive Officer of Kestra Medical Technologies, Ltd. (KMTS), sold 15,000 shares in an open‑market transaction on April 15, 2026. The reported weighted average sale price was $20.04, producing total proceeds of approximately $300,671. This was a sale (not a purchase or exercise).

Key Details

• Transaction date: 2026-04-15 (reported on Form 4 filed 2026-04-16).
• Sale details: 15,000 shares disposed; weighted average price $20.04; total proceeds ≈ $300,671.
• Price range: shares sold at prices between $20.0000 and $20.2200 (weighted average = $20.04).
• Plan/footnotes: Sale occurred pursuant to a Rule 10b5‑1 trading plan adopted September 29, 2025. The filing notes the price shown is a weighted average and offers to provide per‑price share counts on request.
• Shares owned after transaction: Not specified in the provided excerpt.
• Filing timeliness: Report filed the day after the transaction; no late filing indicated.

Context This was a planned sale under a 10b5‑1 trading plan, which typically means the trades were pre‑arranged according to a predetermined schedule. Sales do not necessarily indicate the insider’s view on the company’s prospects; the 10b5‑1 note suggests routine or preapproved disposition rather than opportunistic trading.